Showing results (921-930 of 991) with videos related to
Sort By:
Pageof 100
Personalized Medicine|July 16, 2025
Optimizing breast cancer therapy: chemoressitance and machine learning for precision predictionMartina Lichtenfels, Matheus G S Dalmolin, Julia Caroline Marcolin, et al.Science (New York, N.Y.)|April 19, 2014
Structural basis for assembly and function of a heterodimeric plant immune receptorSimon J Williams, Kee Hoon Sohn, Li Wan, et al.Plos Genetics|May 17, 2021
DEFECTIVE EMBRYO AND MERISTEMS genes are required for cell division and gamete viability in ArabidopsisChin Hong Lee, Nathaniel P Hawker, Jonathan R Peters, et al.European Journal of Cancer (Oxford, England : 1990)|June 20, 2022
Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy's initial experience with its first 100 patientsLambros Tselikas, Antoine Dardenne, Thierry de Baere, et al.The Journal of Invasive Cardiology|March 12, 2020
Transcatheter Valve Implantation for Failed Surgical Aortic and Mitral Bioprostheses: A Single-Center ExperienceJerry Lipinski, Sandeep M Patel, Toral R Patel, et al.Neurobiology of Disease|April 6, 2019
Quantitative ultrasound and apoptotic death in the neonatal primate brainIvan M Rosado-Mendez, Kevin K Noguchi, Laura Castañeda-Martinez, et al.Acta Crystallographica. Section D, Biological Crystallography|June 21, 2008
Federated repositories of X-ray diffraction imagesSteve Androulakis, Jason Schmidberger, Mark A Bate, et al.Plos Computational Biology|October 24, 2022
Engineering indel and substitution variants of diverse and ancient enzymes using Graphical Representation of Ancestral Sequence Predictions (GRASP)Gabriel Foley, Ariane Mora, Connie M Ross, et al.Proceedings of the National Academy of Sciences of the United States of America|February 22, 2023
Exploiting the intrinsic misfolding propensity of the KRAS oncoproteinKobe Janssen, Filip Claes, Dido Van de Velde, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2023
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET InhibitionRichard Riedel, Jana Fassunke, Andreas H Scheel, et al.Pageof 100